It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The retinal pigmented epithelium (RPE) is a monolayer of multifunctional cells located at the back of the eye. High membrane turnover and polarization, including formation of actin-based apical microvilli, are essential for RPE function and retinal health. Herein, we demonstrate an important role for βA3/A1-crystallin in RPE. βA3/A1-crystallin deficiency leads to clathrin-mediated epidermal growth factor receptor (EGFR) endocytosis abnormalities and actin network disruption at the apical side that result in RPE polarity disruption and degeneration. We found that βA3/A1-crystallin binds to phosphatidylinositol transfer protein (PITPβ) and that βA3/A1-crystallin deficiency diminishes phosphatidylinositol 4,5-biphosphate (PI(4,5)P2), thus probably decreasing ezrin phosphorylation, EGFR activation, internalization, and degradation. We propose that βA3/A1-crystallin acquired its RPE function before evolving as a structural element in the lens, and that in the RPE, it modulates the PI(4,5)P2 pool through PITPβ/PLC signaling axis, coordinates EGFR activation, regulates ezrin phosphorylation and ultimately the cell polarity.
Shang et al. utilize a conditional Cryba1 knockout mouse model to demonstrate a key role for βA3/A1-crystallin in retinal pigmented epithelium. As a result of βA3/A1-crystallin deficiency, the authors report EGFR endocytosis defects and actin network disruption which leads to polarity disruption and degeneration through PITP β/PLC signaling.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details





1 University of Pittsburgh School of Medicine, Department of Ophthalmology, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
2 Dean McGee Eye Institute, University of Oklahoma Health Science Center, Oklahoma City, USA (GRID:grid.266902.9) (ISNI:0000 0001 2179 3618)
3 Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)
4 Kodiak Sciences, Palo Alto, USA (GRID:grid.21107.35)
5 University of Pittsburgh School of Medicine, Department of Ophthalmology, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); Institut de la Vision, INSERM, CNRS, Sorbonne Université, Paris, France (GRID:grid.21925.3d)
6 National Eye Institute, National Institutes of Health, Bethesda, USA (GRID:grid.280030.9) (ISNI:0000 0001 2150 6316)
7 University of Pittsburgh School of Medicine, Department of Cell Biology and Center for Biologic Imaging, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)
8 University of Pittsburgh School of Medicine, Department of Ophthalmology, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000); Wilmer Eye Institute, The Johns Hopkins University School of Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311); University of Pittsburgh School of Medicine, Department of Cell Biology and Center for Biologic Imaging, Pittsburgh, USA (GRID:grid.21925.3d) (ISNI:0000 0004 1936 9000)